Work

Lopinavir/Ritonavir Versus Darunavir Plus Ritonavir for HIV Infection: A Cost-Effectiveness Analysis for the United States

Year: 2013

Type: article

Source: PharmacoEconomics

DOI: 10.1007/s40273-013-0048-3

Authors: Kit N. Simpson, Pamela P. Pei, Jörgen Möller, Robert W. Baran, Birgitta Dietz, William Woodward, Kristen Migliaccio-Walle, J. Jaime Caro

Institutions: Medical University of South Carolina, Massachusetts General Hospital, United BioSource Corporation (United Kingdom), Abbott (United States), Abbott (Germany), Institute for Clinical and Economic Review, McGill University

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2005333158

FWCI: 2.424

Cites: 70

Cited by: 23

Related to: 10